Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952779287> ?p ?o ?g. }
- W2952779287 endingPage "3123.e5" @default.
- W2952779287 startingPage "3117" @default.
- W2952779287 abstract "Agonistic antibodies targeting the tumor necrosis factor (TNF) superfamily of co-stimulatory receptors (TNFRSF) are progressing through various stages of clinical development for cancer treatment, but the desired and defining features of these agents for optimal biological activity remain controversial. One idea, based on recent studies with CD40, is that non-ligand-blocking antibodies targeting membrane-distal cysteine-rich domain 1 (CRD1) have superior agonistic activities compared with ligand-blocking antibodies targeting more membrane-proximal CRDs. Here, we determined the binding and functional characteristics of a panel of antibodies targeting CRDs 1-4 of OX40 (also known as TNFRSF4 or CD134). In striking contrast to CD40, we found that ligand-blocking CRD2-binding and membrane-proximal CRD4-binding anti-OX40 antibodies have the strongest agonistic and anti-tumor activities. These findings have important translational implications and further highlight that the relationship between epitope specificity and agonistic activity will be an important issue to resolve on a case-by-case basis when optimizing antibodies targeting different co-stimulatory tumor necrosis factor receptors (TNFRs)." @default.
- W2952779287 created "2019-06-27" @default.
- W2952779287 creator A5002656825 @default.
- W2952779287 creator A5004118353 @default.
- W2952779287 creator A5005770383 @default.
- W2952779287 creator A5006463781 @default.
- W2952779287 creator A5007382545 @default.
- W2952779287 creator A5007595073 @default.
- W2952779287 creator A5013760474 @default.
- W2952779287 creator A5035634528 @default.
- W2952779287 creator A5038447904 @default.
- W2952779287 creator A5042641999 @default.
- W2952779287 creator A5049154569 @default.
- W2952779287 creator A5062100136 @default.
- W2952779287 creator A5091346041 @default.
- W2952779287 creator A5091904164 @default.
- W2952779287 date "2019-06-01" @default.
- W2952779287 modified "2023-10-17" @default.
- W2952779287 title "Ligand-Blocking and Membrane-Proximal Domain Targeting Anti-OX40 Antibodies Mediate Potent T Cell-Stimulatory and Anti-Tumor Activity" @default.
- W2952779287 cites W1964162947 @default.
- W2952779287 cites W1971793099 @default.
- W2952779287 cites W1982861708 @default.
- W2952779287 cites W1985720487 @default.
- W2952779287 cites W2007980919 @default.
- W2952779287 cites W2016708646 @default.
- W2952779287 cites W2022265958 @default.
- W2952779287 cites W2025322061 @default.
- W2952779287 cites W2039038215 @default.
- W2952779287 cites W2051614379 @default.
- W2952779287 cites W2051803876 @default.
- W2952779287 cites W2053313205 @default.
- W2952779287 cites W2057040546 @default.
- W2952779287 cites W2058089640 @default.
- W2952779287 cites W2065283382 @default.
- W2952779287 cites W2071875829 @default.
- W2952779287 cites W2079350687 @default.
- W2952779287 cites W2084376588 @default.
- W2952779287 cites W2104088439 @default.
- W2952779287 cites W2116157579 @default.
- W2952779287 cites W2128402413 @default.
- W2952779287 cites W2157935840 @default.
- W2952779287 cites W2170149792 @default.
- W2952779287 cites W2345544817 @default.
- W2952779287 cites W2411733041 @default.
- W2952779287 cites W2549757281 @default.
- W2952779287 cites W2774294088 @default.
- W2952779287 cites W2782231020 @default.
- W2952779287 cites W2785376969 @default.
- W2952779287 cites W2807748927 @default.
- W2952779287 cites W2899226403 @default.
- W2952779287 doi "https://doi.org/10.1016/j.celrep.2019.05.027" @default.
- W2952779287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31189099" @default.
- W2952779287 hasPublicationYear "2019" @default.
- W2952779287 type Work @default.
- W2952779287 sameAs 2952779287 @default.
- W2952779287 citedByCount "17" @default.
- W2952779287 countsByYear W29527792872019 @default.
- W2952779287 countsByYear W29527792872020 @default.
- W2952779287 countsByYear W29527792872021 @default.
- W2952779287 countsByYear W29527792872022 @default.
- W2952779287 countsByYear W29527792872023 @default.
- W2952779287 crossrefType "journal-article" @default.
- W2952779287 hasAuthorship W2952779287A5002656825 @default.
- W2952779287 hasAuthorship W2952779287A5004118353 @default.
- W2952779287 hasAuthorship W2952779287A5005770383 @default.
- W2952779287 hasAuthorship W2952779287A5006463781 @default.
- W2952779287 hasAuthorship W2952779287A5007382545 @default.
- W2952779287 hasAuthorship W2952779287A5007595073 @default.
- W2952779287 hasAuthorship W2952779287A5013760474 @default.
- W2952779287 hasAuthorship W2952779287A5035634528 @default.
- W2952779287 hasAuthorship W2952779287A5038447904 @default.
- W2952779287 hasAuthorship W2952779287A5042641999 @default.
- W2952779287 hasAuthorship W2952779287A5049154569 @default.
- W2952779287 hasAuthorship W2952779287A5062100136 @default.
- W2952779287 hasAuthorship W2952779287A5091346041 @default.
- W2952779287 hasAuthorship W2952779287A5091904164 @default.
- W2952779287 hasBestOaLocation W29527792871 @default.
- W2952779287 hasConcept C105795698 @default.
- W2952779287 hasConcept C116569031 @default.
- W2952779287 hasConcept C118552586 @default.
- W2952779287 hasConcept C144745244 @default.
- W2952779287 hasConcept C159654299 @default.
- W2952779287 hasConcept C170493617 @default.
- W2952779287 hasConcept C17991360 @default.
- W2952779287 hasConcept C185592680 @default.
- W2952779287 hasConcept C187898756 @default.
- W2952779287 hasConcept C195616568 @default.
- W2952779287 hasConcept C203014093 @default.
- W2952779287 hasConcept C2779448149 @default.
- W2952779287 hasConcept C33923547 @default.
- W2952779287 hasConcept C45121317 @default.
- W2952779287 hasConcept C502942594 @default.
- W2952779287 hasConcept C542903549 @default.
- W2952779287 hasConcept C55493867 @default.
- W2952779287 hasConcept C71924100 @default.
- W2952779287 hasConcept C86803240 @default.
- W2952779287 hasConcept C95444343 @default.
- W2952779287 hasConceptScore W2952779287C105795698 @default.